Scott M Stevens

Summary

Affiliation: LDS Hospital
Country: USA

Publications

  1. ncbi Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis
    Scott M Stevens
    LDS Hospital and University of Utah, Salt Lake City, Utah 84143, USA
    Ann Intern Med 140:985-91. 2004
  2. ncbi Risk of symptomatic DVT associated with peripherally inserted central catheters
    R Scott Evans
    Medical Informatics, Intermountain Healthcare, Salt Lake City, UT, USA
    Chest 138:803-10. 2010
  3. ncbi The use of a fixed high sensitivity to evaluate five D-dimer assays' ability to rule out deep venous thrombosis: a novel approach
    Scott M Stevens
    Department of Internal Medicine, University of Utah, Salt Lake City, UT 84143, USA
    Br J Haematol 131:341-7. 2005
  4. ncbi Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy
    Chandramouli Banerjee
    University of Utah, Salt Lake City, USA
    Clin Appl Thromb Hemost 16:345-50. 2010
  5. ncbi Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis
    Stacy A Johnson
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA
    JAMA 303:438-45. 2010
  6. ncbi Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
    Jeffrey L Anderson
    Cardiovascular Department, LDS Hospital, Intermountain Healthcare, Salt Lake City, UT, USA
    Circulation 116:2563-70. 2007

Collaborators

Detail Information

Publications6

  1. ncbi Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis
    Scott M Stevens
    LDS Hospital and University of Utah, Salt Lake City, Utah 84143, USA
    Ann Intern Med 140:985-91. 2004
    ..Repeated testing is costly and inconvenient, and patients are sometimes less likely to return for follow-up tests...
  2. ncbi Risk of symptomatic DVT associated with peripherally inserted central catheters
    R Scott Evans
    Medical Informatics, Intermountain Healthcare, Salt Lake City, UT, USA
    Chest 138:803-10. 2010
    ..PICC insertion teams and other health-care providers need to understand the risk factors so that they can develop methods to prevent DVT...
  3. ncbi The use of a fixed high sensitivity to evaluate five D-dimer assays' ability to rule out deep venous thrombosis: a novel approach
    Scott M Stevens
    Department of Internal Medicine, University of Utah, Salt Lake City, UT 84143, USA
    Br J Haematol 131:341-7. 2005
    ..These findings should be subjected to a prospective management study, as a small reduction in sensitivity from our findings could result in a clinically relevant decrease in negative predictive value...
  4. ncbi Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy
    Chandramouli Banerjee
    University of Utah, Salt Lake City, USA
    Clin Appl Thromb Hemost 16:345-50. 2010
    ..Conclusion: We present what we believe is the first case of atypical calciphylaxis thought to be attributable to warfarin treated with a therapeutic substitution of anticoagulant and HBOT leading to resolution of cutaneous lesions...
  5. ncbi Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis
    Stacy A Johnson
    Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA
    JAMA 303:438-45. 2010
    ..Patients with an initial negative CUS result often require repeat CUS after 5 to 7 days. Whole-leg CUS may exclude proximal and distal DVT in a single evaluation...
  6. ncbi Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
    Jeffrey L Anderson
    Cardiovascular Department, LDS Hospital, Intermountain Healthcare, Salt Lake City, UT, USA
    Circulation 116:2563-70. 2007
    ..Pharmacogenetic-guided dosing of warfarin is a promising application of "personalized medicine" but has not been adequately tested in randomized trials...